Indivior Share Discussion Threads

[gibbs1] 12/6/2023 07:59

12 June 2023

For Immediate Release

Indivior to Commence Trading on Nasdaq

Company to Ring Opening Bell June 14 to Bring Awareness to Addiction Treatment;

Company Will Maintain Premium Listing on London Stock Exchange

Richmond, VA, June 12, 2023 - Indivior PLC (LSE: INDV), a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD) and serious mental illnesses, today announces that the U.S. Securities & Exchange Commission (SEC) declared its registration statement on Form 20-F effective on June 9. Trading in Indivior ordinary shares on the Nasdaq Global Select Market will commence at U.S. market open today.

Indivior will retain its premium listing on the London Stock Exchange and inclusion in the FTSE 250 index, and its ordinary shares will trade on both exchanges under the ticker symbol "INDV." The Company also notes that no shares are being offered as part of the additional U.S. listing.

[casholaa] 08/6/2023 15:57

Difficult to say, I think that the nasdaq is the general tech listed companies and the US tech 100 is like ftse 100 for the top 100 tech stocks. I could be erroneous though.

[youngers] 08/6/2023 15:36

Tracker funds own something like 16% of US corporates according to an FT article from last year. Not sure that applies to bottom end of Nasdaq though

[ricky46] 08/6/2023 13:54

It would be good to know how many funds track the Nasdaq index that this is joining next week? They will all be buying into this.

[youngers] 06/6/2023 17:18

Great momentum today with a positive finish. Hopefully this builds through the Nasdaq listing next week

[villarich] 06/6/2023 08:08

Back to £20 we go...

[casholaa] 05/6/2023 14:40

US independence was successful. No taxation without representation!

[steeplejack] 05/6/2023 14:15

The marketmakers will be having extra fun arbitraging with the US quote in due course.Charles Schwab in the US don't charge commission and (of course theres no transaction stamp duty to pay)so you can factor in a price differential between the US and UK quotes of around 0.6% ie about 10p even before the MMs get up to their tricks.I always feel appreciative when i can nip into the US market and pay effectively nothing to deal.The very idea must be deeply shocking to the UK government.

[gregmorg] 05/6/2023 10:30

Well, Steeplejack, that could be a really nice start!! Certainly we hope for big gains after this roller coaster of a ride, and all this time, BUT seeing is the real test as we all know!

[steeplejack] 05/6/2023 09:56

ShearClass over on LSE has posted an interesting analysis.Alkermes (ALKS) is a NASDAQ listed pharma that market another opoid dependence drug (vivitrol). Their Q1 revenues were $287m with $96.7m of this coming from vivitrol, up from $84.7m in the prior year. They're trading at an enterprise value of $4.5b, so EV/Sales ratio is ~3.9. INDV is forecasting 2023 sales of $1.01b and has a current EV of ~$2.4b, so is on an EV/Sales of just 2.3x Gives INDV has significantly faster sales growth, higher gross margins & has now removed the legal overhang I think there is significant upside potential over the coming weeks post next Monday's NASDAQ listing. Aligning with the Alkermes EV/s would put the share price at around £26...

[youngers] 05/6/2023 09:41

Thanks 74tom. Great summary and completely agree with your thinking

[74tom] 05/6/2023 09:01

Underlying EPS was $0.41 in Q1, annualised this is EPS of £1.32 and puts these shares on a forward PE of just 12x... With sublocade growth averaging 12.5% a quarter over the last 6 quarters this looks far too cheap. Suspect it rerates to between 15-20x FY23 PE once on NASDAQ (£20-26)

[youngers] 05/6/2023 08:25

Good start! Now let’s build from there please

[youngers] 05/6/2023 07:36

Hoping for a pop here this morning 🙏

[steeplejack] 04/6/2023 22:32

I'm sure that Indivior bust a gut to get a settlement over the line before the Nasdaq listing.You have to factor in that these sort of legal proceedings are endemic when it comes to holding a company like Indivior.Even Glaxo recently got cited in respect of Zantac,the drug that transformed the group back in the 1980s.There's always going to be some legal johnny,rightly or wrongly, in the wings looking to the main chance with these drug companies.It's a question of evaluating whether the ever present threat of litigation is discounted when assessing the company's trading prospects.Fairly impossible task unless you're clairvoyant!Every litigation episode takes a bit of bounce out of the bungee i suppose.So,i don't think a race back to £20 is likely short term but maybe high teens is possible if the US listing gets off to a good start.

[gregmorg] 03/6/2023 10:35

Mm 42 plus US States might well require an awful lot of lawyers even to cover the field but the deal is done and for once well within estimates -so where’s the beef! Will see how the share price progresses now especially with the12June added listing

[youngers] 02/6/2023 19:32

Interesting that a 100m settlement is in line with a 290m provision. That’s some bloody legal bill!!

Only ones who ever wins are the lawyers

[youngers] 02/6/2023 19:13

Brilliant news!! Back to £20 next week?

[dealy] 02/6/2023 18:24

Great news tonight (I think).